147 related articles for article (PubMed ID: 35354962)
1. IMM-H007 attenuates isoprenaline-induced cardiac fibrosis through targeting TGFβ1 signaling pathway.
Wang SX; Feng YN; Feng S; Wu JM; Zhang M; Xu WL; Zhang YY; Zhu HB; Xiao H; Dong ED
Acta Pharmacol Sin; 2022 Oct; 43(10):2542-2549. PubMed ID: 35354962
[TBL] [Abstract][Full Text] [Related]
2. IMM-H007 improves heart function via reducing cardiac fibrosis.
Ge W; Zhang W; Gao R; Li B; Zhu H; Wang J
Eur J Pharmacol; 2019 Aug; 857():172442. PubMed ID: 31181209
[TBL] [Abstract][Full Text] [Related]
3. The cordycepin derivative IMM-H007 improves endothelial dysfunction by suppressing vascular inflammation and promoting AMPK-dependent eNOS activation in high-fat diet-fed ApoE knockout mice.
Wang MJ; Peng XY; Lian ZQ; Zhu HB
Eur J Pharmacol; 2019 Jun; 852():167-178. PubMed ID: 30826323
[TBL] [Abstract][Full Text] [Related]
4. Metformin attenuates angiotensin II-induced TGFβ1 expression by targeting hepatocyte nuclear factor-4-α.
Chen R; Feng Y; Wu J; Song Y; Li H; Shen Q; Li D; Zhang J; Lu Z; Xiao H; Zhang Y
Br J Pharmacol; 2018 Apr; 175(8):1217-1229. PubMed ID: 28230250
[TBL] [Abstract][Full Text] [Related]
5. Metformin attenuates renal fibrosis in both AMPKα2-dependent and independent manners.
Feng Y; Wang S; Zhang Y; Xiao H
Clin Exp Pharmacol Physiol; 2017 Jun; 44(6):648-655. PubMed ID: 28273365
[TBL] [Abstract][Full Text] [Related]
6. Liquiritigenin attenuates isoprenaline‑induced myocardial fibrosis in mice through the TGF‑β1/Smad2 and AKT/ERK signaling pathways.
Li L; Fang H; Yu YH; Liu SX; Yang ZQ
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34328199
[TBL] [Abstract][Full Text] [Related]
7. Exercise Training Attenuates Acute β-Adrenergic Receptor Activation-Induced Cardiac Inflammation via the Activation of AMP-Activated Protein Kinase.
Zhang M; Alemasi A; Zhao M; Xu W; Zhang Y; Gao W; Yu H; Xiao H
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298222
[TBL] [Abstract][Full Text] [Related]
8. [AMP-activated kinase activation inhibits transforming growth factor-β1 production in cardiac fibroblasts via targeting C/EBPβ].
Xiao H; Piao CS; Chen RF; Zhang YY
Sheng Li Xue Bao; 2017 Apr; 69(2):123-128. PubMed ID: 28435970
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of stimulation and binding characteristics of adenosine analogs to AMP-activated protein kinase.
Gao F; Qian YJ; Chen FH; Zhu HB
J Asian Nat Prod Res; 2019 Sep; 21(9):916-927. PubMed ID: 30187782
[TBL] [Abstract][Full Text] [Related]
10. Aucubin Protects against TGFβ1-Induced Cardiac Fibroblasts Activation by Mediating the AMPKα/mTOR Signaling Pathway.
Xiao Y; Chang W; Wu QQ; Jiang XH; Duan MX; Jin YG; Tang QZ
Planta Med; 2018 Jan; 84(2):91-99. PubMed ID: 28841738
[TBL] [Abstract][Full Text] [Related]
11. Gelsolin is an important mediator of Angiotensin II-induced activation of cardiac fibroblasts and fibrosis.
Jana S; Aujla P; Hu M; Kilic T; Zhabyeyev P; McCulloch CA; Oudit GY; Kassiri Z
FASEB J; 2021 Oct; 35(10):e21932. PubMed ID: 34549830
[TBL] [Abstract][Full Text] [Related]
12. Oleanolic acid derivative alleviates cardiac fibrosis through inhibiting PTP1B activity and regulating AMPK/TGF-β/Smads pathway.
Wang AH; Ma HY; Yi YL; Zhu SJ; Yu ZW; Zhu J; Mei S; Bahetibike S; Lu YQ; Huang LT; Yang RY; Rui-Wang ; Xiao SL; Qi R
Eur J Pharmacol; 2023 Dec; 960():176116. PubMed ID: 38059443
[TBL] [Abstract][Full Text] [Related]
13. Asenapine maleate inhibits angiotensin II-induced proliferation and activation of cardiac fibroblasts via the ROS/TGFβ1/MAPK signaling pathway.
Wu HH; Meng TT; Chen JM; Meng FL; Wang SY; Liu RH; Chen JN; Ning B; Li Y; Su GH
Biochem Biophys Res Commun; 2021 May; 553():172-179. PubMed ID: 33773140
[TBL] [Abstract][Full Text] [Related]
14. HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome.
Hermida N; Markl A; Hamelet J; Van Assche T; Vanderper A; Herijgers P; van Bilsen M; Hilfiker-Kleiner D; Noppe G; Beauloye C; Horman S; Balligand JL
Cardiovasc Res; 2013 Jul; 99(1):44-54. PubMed ID: 23542580
[TBL] [Abstract][Full Text] [Related]
15. A novel AMPK activator improves hepatic lipid metabolism and leukocyte trafficking in experimental hepatic steatosis.
Peng X; Li J; Wang M; Qu K; Zhu H
J Pharmacol Sci; 2019 Jun; 140(2):153-161. PubMed ID: 31253430
[TBL] [Abstract][Full Text] [Related]
16. Chikusetsu saponin IVa attenuates isoprenaline-induced myocardial fibrosis in mice through activation autophagy mediated by AMPK/mTOR/ULK1 signaling.
Wang L; Yuan D; Zheng J; Wu X; Wang J; Liu X; He Y; Zhang C; Liu C; Wang T; Zhou Z
Phytomedicine; 2019 May; 58():152764. PubMed ID: 31005723
[TBL] [Abstract][Full Text] [Related]
17. Zerumbone, a humulane sesquiterpene from Syringa pinnatifolia, attenuates cardiac fibrosis by inhibiting of the TGF-β1/Smad signaling pathway after myocardial infarction in mice.
Li J; Ge F; Wuken S; Jiao S; Chen P; Huang M; Gao X; Liu J; Tu P; Chai X; Huang L
Phytomedicine; 2022 Jun; 100():154078. PubMed ID: 35405613
[TBL] [Abstract][Full Text] [Related]
18. Exacerbated cardiac fibrosis induced by β-adrenergic activation in old mice due to decreased AMPK activity.
Wang J; Song Y; Li H; Shen Q; Shen J; An X; Wu J; Zhang J; Wu Y; Xiao H; Zhang Y
Clin Exp Pharmacol Physiol; 2016 Nov; 43(11):1029-1037. PubMed ID: 27389807
[TBL] [Abstract][Full Text] [Related]
19. Preclinical pharmacokinetic study of a novel lipid-lowering agent, IMM-H007.
Zhang ZL; Liu WQ; Deng XZ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8939-8950. PubMed ID: 30575938
[TBL] [Abstract][Full Text] [Related]
20. IMM-H007, a novel small molecule inhibitor for atherosclerosis, represses endothelium inflammation by regulating the activity of NF-κB and JNK/AP1 signaling.
Yu J; Ming H; Li HY; Yu B; Chu M; Zhu H; Zhu X
Toxicol Appl Pharmacol; 2019 Oct; 381():114732. PubMed ID: 31454633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
